ArticleBiomedicines2026

Effect of First-Line Combination Systemic Therapy on Favorable-Risk Clear Cell Renal Cell Carcinoma: A Retrospective Study.

Soon Il Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.